For the year ending 2025-12-31, CRCT had $24,076K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 76,705 |
| Depreciation and amortization (including amortization of debt issuance costs) | 24,439 |
| Reversal of (provision for) expected losses | -1,695 |
| Impairments | 642 |
| Stock-based compensation | 34,791 |
| Deferred income tax | 26,117 |
| Non-cash lease expense | 3,460 |
| Provision for inventory obsolescence, net | -19,706 |
| Unrealized foreign currency (gain) / loss | 1,077 |
| Other | 714 |
| Accounts receivable | -12,618 |
| Inventories | -41,161 |
| Prepaid expenses and other current assets | 2,429 |
| Other assets | 3,223 |
| Accounts payable | 16,854 |
| Accrued expenses, other current liabilities and other non-current liabilities | -8,774 |
| Operating lease liabilities | -3,968 |
| Deferred revenue | 5,029 |
| Net cash and cash equivalents provided by operating activities | 200,230 |
| Purchase of marketable securities | 0 |
| Proceeds from maturities of marketable securities | 85,074 |
| Purchases of property and equipment, including capitalized software development costs | 24,417 |
| Net cash and cash equivalents provided by (used in) investing activities | 60,657 |
| Repurchases of common stock | 24,748 |
| Proceeds from exercise of stock options | 0 |
| Employee tax withholding payments on stock-based awards | 10,594 |
| Cash dividend | 202,103 |
| Net cash and cash equivalents used in financing activities | -237,445 |
| Effect of exchange rate on changes on cash and cash equivalents | 634 |
| Net increase (decrease) in cash and cash equivalents | 24,076 |
| Cash and cash equivalents at beginning of period | 232,140 |
| Cash and cash equivalents at end of period | 256,216 |
CRCT
CRCT